Skoči na glavni sadržaj

Izvorni znanstveni članak

Insulin pump in treating patients with diabetes type 1

Veselin Škrabić ; KB Split, Klinika za dječje bolesti
Maja Milanović ; Split, Klinika za dječje bolesti
Nerina Cvjetković ; Split, Klinika za dječje bolesti


Puni tekst: hrvatski doc 164 Kb

str. 5-9

preuzimanja: 1.313

citiraj

Puni tekst: engleski doc 22 Kb

str. 9-9

preuzimanja: 294

citiraj


Sažetak

Diabetes type 1 (T1D) originates from beta cell destruction. Heredity and environmental factors influence the genesis of T1D. The use of an insulin pump in patients with T1D improves their quality of life and attains better regulation of glycaemia, which reduces the risk of complications. In this study we documented the variation in HbA1c values before and after using insulin pumps and its influence on body mass index (BMI-SDS) changes, the frequency of severe hypoglycaemia and ketoacidosis (DKA). HbA1c values were greatly reduced after insulin pump use. BMI-SDS confirmed the expected significant growth using the insulin pump in regards to free eating habits. The frequency of severe hypoglycaemia and DKA in our patients was very small compared to results published in other diabetic centres throughout the world.

Ključne riječi

DIABETES MELLITUS, TYPE 1 – farmakoterapija; INSULIN INFUSION SYSTEMS; DIABETIC KETOACIDOSIS – epidemiology; HYPOGLYCEMIA – epidemiology; HEMOGLOBIN A, GLYCOSYLATED – analysis; BODY MASS INDEX

Hrčak ID:

22263

URI

https://hrcak.srce.hr/22263

Datum izdavanja:

3.4.2008.

Podaci na drugim jezicima: hrvatski

Posjeta: 3.514 *